Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8229689 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 6 Pages |
Abstract
In esophageal and gastroesophageal cancers, pCR seems to significantly increase overall survival in patients undergoing neoadjuvant chemoradiotherapy. Specifically, the data suggest that patients with pCR are two to three times more likely to survive than are those with residual tumor at esophagectomy. Moreover, these data suggest that 33-36% more patients survive when pCR is achieved than when it is not.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Richard V. B.A., Achilles J. M.D., Peter A.S. M.D.,